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Introduction: Massive hemoptysis is an uncommon but life-threatening emergency. The loss 
o f  at least 600 ml o f  blood within a 48-hour period has been associated with a high mortality rate. 
Although most commonly hemoptysis caused by valvulopathies is not massive enough to be life 
threatening, have been reported cases o f  asphyxia after pulmonary hemorrhage in patients with 
mitral stenosis. Hemoptysis and occurrence o f pulmonary edema associated with end stage and 
severe mitral stenosis would be an indication for early surgery.
Aim of the study: To assess the clinical, laboratory aspects and the presentation o f a clinical 
case with massive hemoptysis and mitral stenosis occurred at mature age.
Material and methods: The patient was hospitalized, examined, evaluated in Hospital "Saint 
Trinity", Chisinau.
Results: Patient aged 45 years was hospitalized in Emergency Department due to pulmonary 
hemorrhage (>21/24 hours) and hemorrhagic shock. From anamnesis, the patient is known with 
rheumatic heart defect -  mitral stenosis at the age o f  25 years. It is o f  interest that massive 
hemoptysis in this patient occurred as a first manifestation o f  mitral stenosis. He administered 
anticoagulation therapy -  Warfarin. Physical examination on admission revealed a normal weight 
patient in critical condition. Relative limits were deflected: left heart border -  by 4 cm and right -  
by 2 cm, arrhythmic heart sounds, atrial fibrillation, diastolic murmur, distended jugular, peripheral 
edema at the calves, lower liver edge - 4 cm below the right costal border.
Echocardiographic examination revealed the patient's hardened, calcified aorta walls, indurated 
annulus and aortic valves, calcified, with formation o f  the moderate regurgitation (II degree), mitral 
annulus calcification, mitral valves endured pronounced calcified stenosis formation, transmitral 
pressure gradient -  36 mmHg., mitral orifice area -  1,5 cm2, considerable dilatation o f  the left atrium, 
right atrium, moderate dilatation o f the right ventricle, asymmetrical hypertrophy o f  the left ventricular 
myocardium, ejection fraction -  60%. Tricuspid valve insufficiency -  IIIrd gr. Pulmonary artery valve 
insufficiency -  IInd gr. Severe pulmonary hypertension, pulmonary artery pressure -  68 mmHg. Initial 
treatment consisted from antishock therapy (ice bag. airway maintenance, oxygen 2-4 1/min, permanent 
venous access, fluid resuscitation, hemostasis and hemodynamic correction), (3-blockers and digitalis 
administration. Patient's general condition improved by stopping hemoptysis and reducing dyspnea, but 
pulmonary bleeding complications required a special intervention-the reference to cardiac surgeon.
Conclusion: Our patient's history and clinical course illustrate that severe hemoptysis may 
complicate moderate degrees o f  mitral stenosis. The patient had the high thromboembolic risk 
necessitated anticoagulation therapy. Mitral valve operation would appear to be beneficial in 
cessation o f  hemoptysis.
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Introduction: In patients with acute myocardial infarction, elevation o f  plasma glucose levels 
is associated with worse outcomes.
Purpose and Objectives: The aim o f  this study was to evaluate the prevalence o f  newly
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hyperglycemia and the association between admission hyperglycemia and in-hospital m ortality in 
patients with acute myocardial infarction (AMI).
Materials and Methods: Retrospective observational study included 125 consecutive patients 
(<70yo) with AMI hospitalized at “Sfinta Treime” Municipal Hospital, Chisinau, in period 1.01.2012- 
31.12.2012. Patients with known diabetes mellitus (n=25) or non-diabetic with fasting hyperglycemia 
(n=17) were excluded, while those with previous myocardial infarction or stroke were enrolled.
The study sample was divided into normoglycemic patients (NDN; n=50; fasting glucose 
<6.1mmol/l and 2-h post-load glucose <7.8mmol/l) and those with admission hyperglycemia (NDH, 
n=33), without previous history o f  diabetes (admission glucose >7.8mmoI/l).
Data were analyzed in MS Excel (2010). Results are presented as means and SD. Pearson corre­
lation coefficient (r) was determined for each variable and p<0.05 was considered statistically significant.
Results: The results o f the present investigation confirm that, even among non-diabetic patients, 
the prevalence o f elevated glucose levels upon admission for AMI is high (n=33; 33%), the prevalence 
was higher in men (21 vs. 12). Compared to normoglycemic, NDH patients were younger (53.64yo vs. 
57.30). As expected, mortality were significant lower in NDN (n=2; 4% vs. n=10; 30%). Mortality was 
higher in males (7 vs. 3 in NDH; 2 vs. 0 in NDN). In NDH group death occurred predominantly in 
younger group (9 patients <60yo and 1 person >60yo, compared to 1:1 in NDN). In both groups, 
admission glucose levels were higher in non-survivors (5.68±1.24 vs. 5.64±0.92 in NDN and 
10.85±2.44 vs. 10.13±2.34 in NDH; p<0.001). A strong uphill correlation was observed between 
admission glucose and mortality (r-coefficient 0.53). NDH had longer hospital stay (456.00±30.99h vs. 
426.00h±21.08; p<0.001). Death occurred earlier in NDH (37.66h±15.19 vs. 72.70h, p<0.05).
It suggests that the presence o f  hyperglycemia in subjects who present with AMI offers a 
survival disadvantage.
Conclusions: Hyperglycemia on admission is an independent predictor o f  poor in-hospital 
outcome and mortality in AMI and could be used in the stratification o f  risk in these patients. The 
impact o f  hyperglycemia as a risk factor in AMI is more pronounced in younger patients (<60yo) 
compared to those older than 60yo.
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Introduction: Dilated cardiomyopathy (DCM) is a common cause o f  congestive cardiac 
failure all over the world. The incidence is 5-8 cases per 100 000 population per year, men suffer 2- 
3 times more often than women, mean age o f  patients - 30 to 45 years, rarely it is met in elderly 
patients, as it was in our case. Regardless o f the type o f  DCM, many years they are asymptomatic 
and first manifestation usually being an advanced state with features o f  congestive cardiac failure 
III-IV (NYHA) or with complications like arrhythmia and sudden cardiac death and have a high 
mortality rate o f 15.0-50.0% at 5 years. Treatment o f  DCM is aimed to reduce the congestive 
symptoms and the number o f episodes o f decompensations and to improve the quality o f  life.
Materials and methods: We present a literary reference to cardiomyopathy and a clinical case o f  
DCM. Demonstration o f a case is o f great interest to clinicians in terms o f the relevance o f  the disease.
Results: This is a report o f successful management of a patient with severe DCM, who was ad­
mitted at the first time with congestive heart failure IV (NYHA), severe multiple valvular insufficiencies, 
which after 3 weeks o f conservative treatment was compensated till CHF III (NYHA). After undergoing a 
successful heart surgery with aortic and mitral valve prostheses has returned to normal life.
Conclusions: The outlook for patients with cardiac failure has improved substantially in the last 15 
years. This is largely due to the application o f the results o f multicentre clinical trials o f  new and older
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